90 likes | 121 Views
u201cCoherent Market Insights u201cDENDRIMERS AND POLYMER DRUGS CONJUGATE MARKET u2013 GLOBAL TRENDS, ESTIMATES AND FORECASTS, 2020-2027u2033
E N D
DENDRIMERS & POLYMER DRUGS CONJUGATE MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Dendrimers and Polymer Drugs Conjugate Market - Overview Global Dendrimers and Polymer Drugs Conjugate Market Restraints Disadvantages associated with employment of dendrimers and polymer conjugated drugs may hamper the global Dendrimers And Polymer Conjugate Market growth. Dendrimers are used in pharmaceutical industry, however their biological use is restricted due to their toxicity. The interaction between the positive charge present on the surface area of dendrimers and the negative charge present on the biological membrane leads to membrane erosion and thinning. It disrupts the membrane and can cause cytotoxicity, hematological toxicity and hemolytic toxicity. Hence, this factor may restrain the use of dendrimers and polymers in potential pharmaceutical applications, and also hinder the global dendrimers and polymer drugs conjugate market growth. Dendrimers, and polymer drug conjugates are nano–sized medicines used for therapeutic applications. In polymer drug conjugates, polymers are covalently bonded to the drug molecule and the linkers are biologically active. Dendrimers are highly water soluble, polyvalent, and have precise molecular weight. They act as carriers of drugs, and facilitate their administration in the body. Dendrimers also have other applications in diagnostic analyses, target therapy, and vaccines. They are also used for the treatment of cancer. Other commercially available polymer drug conjugates include VivaGel, Dendrimer – docetaxel, and Dendrimer – oxaliplatin among others. Browse Research Reports: https://www.coherentmarketinsights.com/ongoing- insight/dendrimers-and-polymer-drugs-conjugate-market-2628 © Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION It contains astodrimer sodium which is a type of dendrimer. It is the only treatment which is available over the counter, i.e., without prescription. Such partnerships are expected to propel the growth of global dendrimers and polymer drugs conjugate market. Furthermore, in September 2015, AstraZeneca entered a license agreement with Starpharma Holdings Limited. AstraZeneca used their DEP technology, a type of dendrimer drug delivery system, to study several cancer compounds in the early phases of development. Advancements in drug delivery systems with an edge over to the conventional drug delivery system is expected to propel the global dendrimers and polymer drugs conjugate market growth. Dendrimers have more stability and prolonged circulation than the conventional (oral drug delivery system) approach of drug delivery system. Certain dendrimers are about 200 nanometer in size, and their high loading antigen capacity receives stronger responses from immune system than oral vaccines. For example, polyamidoamine (PMAM) is a dendrimer which has a spherical shape. Global Dendrimers and Polymer Drugs Conjugate Market Regional Analysis North America is expected to be the dominant region in the global dendrimers and polymer drugs conjugate market. Presence of manufacturers like Eli Lilly & Co., Dade Behring and Nektar Therapeutics, potential customer base, and frequent research and development activities by key players is expected to drive North America dendrimers and polymer drugs conjugate market growth. Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/2628 © Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION For instance, in November 2016, Nektar Therapeutics commenced its investigational study on NKTR-102. The drug is being studied for the treatment of metastatic breast cancer. It contains irinotecan (dendrimer)/ Topoisomerase I inhibitor, and is currently in the third phase of clinical trial. Global Dendrimers and Polymer Drugs Conjugate Market Key Players Some of the major players operating in the global dendrimers and polymer drugs conjugate market include, Starpharma Holdings Ltd., AstraZeneca Plc., Eli Lilly & Co., Nektar Therapeutics, Dade Behring, Stiefel Laboratories, Cerulean Pharma Inc., Merck KGaA, Qiagen and CTI Biopharma Corp. Global Dendrimers and Polymer Drugs Conjugate Market Taxonomy The global dendrimers and polymer drugs conjugate market is segmented on the basis of dendrimers type, applications, distribution channel, and region. Global Dendrimers and Polymer Drugs Conjugate Market Drivers Product launches, and collaboration activities of manufacturers are expected to boost the global dendrimers and polymer drugs conjugate market growth. For instance, in April 2019, VivaGel was officially launched in Australia by Aspen Pharmacare and commercialized by Starpharma. Vivagel is used for the treatment of bacterial vaginosis, a non-antibiotic therapy. Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/2628 © Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved
ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS Global Leading Equipment and System Manufacturers Marketing Consultancies and the Advertising Industry Component Providers and System Integrators Private and Government organization Distributors, Retailors and Value Added Resellers Outsourcing Companies Healthcare IT Solutions Developers Universities and Business Schools. © Coherent market Insights. All Rights Reserved
KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved
THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved